Credit: Vall d’Hebron Institute of Oncology (VHIO). Published in Cancer Research, findings reveal the potent and prolonged antitumor ...
ANN ARBOR, Michigan — Scientists at the University of Michigan Rogel Cancer Center were optimistic when they identified a small ...
NEW YORK, May 24, 2022 --- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of ...
(Memphis, Tenn.—May 9, 2022) Inhibitors of the protein EZH2 are effective against cancers with SMARCB1 mutations such as rhabdoid tumors ...
NEW ORLEANS – Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras) had a ...
UPTON, NY—When the COVID-19 pandemic hit, scientists across the U.S. Department of Energy’s (DOE) national laboratory complex turned to the ...
With an estimated 2.2 million new cancer cases and 1.8 million deaths globally, lung cancer is the second most commonly ...
Lugano, Switzerland, 20 September 2021 - The first randomised study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more ...
